Side-Effects of Anti-Inflammatory Drugs: Part One Clinical and Epidemiological Aspects: Inflammation and Drug Therapy Series, cartea 1
Editat de K. D. Rainsford, G.P Veloen Limba Engleză Paperback – 16 apr 2012
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (2) | 361.44 lei 43-57 zile | |
SPRINGER NETHERLANDS – 16 apr 2012 | 361.44 lei 43-57 zile | |
SPRINGER NETHERLANDS – 8 mai 2012 | 705.52 lei 43-57 zile |
Preț: 361.44 lei
Preț vechi: 380.47 lei
-5% Nou
Puncte Express: 542
Preț estimativ în valută:
69.18€ • 72.10$ • 57.59£
69.18€ • 72.10$ • 57.59£
Carte tipărită la comandă
Livrare economică 06-20 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9789401097741
ISBN-10: 9401097747
Pagini: 356
Ilustrații: 352 p.
Dimensiuni: 155 x 235 x 19 mm
Greutate: 0.5 kg
Ediția:Softcover reprint of the original 1st ed. 1987
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Inflammation and Drug Therapy Series
Locul publicării:Dordrecht, Netherlands
ISBN-10: 9401097747
Pagini: 356
Ilustrații: 352 p.
Dimensiuni: 155 x 235 x 19 mm
Greutate: 0.5 kg
Ediția:Softcover reprint of the original 1st ed. 1987
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Inflammation and Drug Therapy Series
Locul publicării:Dordrecht, Netherlands
Public țintă
ResearchCuprins
1 Table of Contents.- Section I Clinical and Epidemiological Aspects.- 1 Introduction and historical aspects of the side-effects of anti-inflammatory analgesic drugs.- 2 Epidemiology in the United Kingdom of adverse drug reactions from non-steroidal anti-inflammatory drugs.- 3 Assessment of adverse reactions to NSAIDs: Pre- and post-marketing..- 4 Incidence of serious side effects from non-steroidal anti-inflammatory drugs (NSAIDs) in the USA.- 5 Trends and patterns in adverse drug reactions to non-steroidal anti-inflammatory drugs reported in Sweden.- 6 Rare adverse reactions to non-steroidal anti-inflammatory drugs.- 7 Pyrazolone-induced agranulocytosis: an epidemiological evaluation.- 8 Potential biases influencing interpretation of data from worldwide spontaneous ADR reports.- 9 Prescription-event monitoring of five non-steroidal anti-inflammatory drugs.- 10 Side-effects of non-steroidal anti-inflammatory drugs in children with juvenile rheumatoid arthritis.- 11 Non-steroidal anti-inflammatories: outpatient audit of patient preferences and side-effects in different diseases.- 12 Non-steroidal anti-inflammatories in the elderly.- 13 Ibuprofen overdose — the first year following over-the-counter release.- Section II Drug Interactions and Drug Metabolism.- 14 Drug interactions between the anti-inflammatory drugs and with other agents.- 15 Interactions between non-steroidal anti-inflammatory drugs and angiotensin converting enzyme inhibitors in man.- 16 Responders and non-responders to NSAI drug interactions a neglected problem?.- 17 Biological implications of the metabolic chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drugs.- 18 A medicinal chemist’s perspective of side-effects of anti-inflammatory analgesic drugs.- 19 Genetic andenvironmental aspects of drug metabolism relevant to side-effects in arthritic disease.- 20 Disease drug interactions: utility of the conditional concept for experimental pharmacology and toxicology in the context of inflammation.- 21 Pharmacokinetic profile of ketoprofen in elderly subjects.- 22 The effects of frusemide and Dorbanex on the pharmacokinetic profile of benoxaprofen in elderly subjects.- 23 Enantioselective dispositon of a model non-steroidal anti-inflammatory drug 2-phenylpropionic acid.- Section III Gastrointestinal Tract (Clinical Aspects).- 24 Anti-inflammatory drugs and upper gastrointestinal perforation.- 25 Piroxicam and gastrointestinal ulceration.- 26 Anti-inflammatory drugs and gastrointestinal disease. Reasons for the failure of adverse reaction reporting and surveillance systems to detect a significant association.- 27 An evaluation of the frequency of anti-inflammatory and analgesic drug intake among patients with acute gastrointestinal bleeding.